Skip to main content
Log in

Prävention und Therapie des postoperativen Leberversagens

Prevention and therapy of postoperative liver failure

  • Nachbardisziplinen
  • Published:
Zeitschrift für Herz-,Thorax- und Gefäßchirurgie Aims and scope

Zusammenfassung

Bei Patienten mit vorbestehender Leberzirrhose zeigt sich auch im Rahmen nichthepatobiliär-chirurgischer (N-HPB-)Interventionen ein hohes perioperatives Mortalitäts- und Morbiditätsrisiko infolge eines postoperativen Leberversagens (PLV). Daher sind bei diesem Patientengut, unabhängig von der chirurgischen Fachspezifität, Prävention, Diagnostik und etwaige Therapie des PLV essenziell. Derzeit existiert für N-HPB-Operationen keine einheitliche Definition des PLV. In Analogie zur Definition des PLV durch die International Study Group of Liver Surgery (ISGLS) stellen die progressive Hyperbilirubinämie und Koagulopathie ab dem 5. postoperativen Tag die Kerncharakteristika des PLV dar. Die Child-Turcotte-Pugh-(CTP)-Klassifikation und der Model for End-Stage Liver Disease (MELD) Score sind geeignete Instrumente zur Abschätzung des prospektiven perioperativen Risikos und sollten in die operationsstrategische Planung miteinfließen. Die ISGLS-Klassifikation ist für die postoperative Diagnostik und Behandlung des PLV geeignet. Die Therapie des PLV stellt eine große Herausforderung dar, da derzeit keine kausalen Ansätze existieren und diese lediglich symptomorientiert erfolgt. Daher ist die Prävention des PLV unter Zuhilfenahme eines erfahrenen Hepatologen essenziell.

Abstract

Patients with preexisting cirrhosis who are subjected to hepatobiliary (HBP) or non-hepatobiliary (N-HBP) surgery are expected to bear an exceptionally high risk of morbidity and mortality due to postoperative liver failure (PLV). Therefore, thorough clinical diagnostics, prevention and adequate management of PLV are pivotal for a good outcome irrespective of the type of surgery applied in this particular group of patients. To date there is no standard definition used for PLV. In accordance with International Study Group of Liver Surgery (ISGLS) definition, progressive hyperbilirubinemia and coagulopathy after postoperative day 5 represent the main characteristics implicating PLV. The Child-Turcotte-Pugh (CTP) classification and the model for end-stage liver disease (MELD) score allow a reliable estimation of the perioperative risk and thus provide a useful assistance in planning surgery. The ISGLS classification is helpful in the postoperative diagnosis and treatment of PLV. The treatment of PLV is extremely challenging and limited to counteracting symptoms with no option to cure the underlying liver disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Alfieri S, Carriero C, Caprino P et al (2001) Avoiding early postoperative complications in liver surgery. A multivariate analysis of 254 patients consecutively observed. Dig Liver Dis 33:341–346

    Article  CAS  PubMed  Google Scholar 

  2. Aranha GV, Sontag SJ, Greenlee HB (1982) Cholecystectomy in cirrhotic patients: a formidable operation. Am J Surg 143:55–60

    Article  CAS  PubMed  Google Scholar 

  3. Azoulay D, Castaing D, Krissat J et al (2000) Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 232:665–672

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Balzan S, Belghiti J, Farges O et al (2005) The „50–50 criteria“ on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824–828

    Article  PubMed Central  PubMed  Google Scholar 

  5. Behrns KE, Tsiotos GG, DeSouza NF et al (1998) Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 2:292–298

    Article  CAS  PubMed  Google Scholar 

  6. Chandok N, Watt KD (2010) Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc 85:451–458

    Article  PubMed Central  PubMed  Google Scholar 

  7. Chiu A, Chan LM, Fan ST (2006) Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience. Liver Int 26:695–702

    Article  CAS  PubMed  Google Scholar 

  8. Coelho JC, Claus CM, Machuca TN et al (2004) Liver resection: 10-year experience from a single institution. Arq Gastroenterol 41:229–235

    PubMed  Google Scholar 

  9. Csikesz NG, Nguyen LN, Tseng JF, Shah SA (2009) Nationwide volume and mortality after elective surgery in cirrhotic patients. J Am Coll Surg 208:96–103

    Article  PubMed  Google Scholar 

  10. Cucchetti A, Ercolani G, Cescon M et al (2006) Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J Am Coll Surg 203:670–676

    Article  PubMed  Google Scholar 

  11. Friedman LS (2010) Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc 121:192–204

    PubMed Central  PubMed  Google Scholar 

  12. Hemming AW, Reed AI, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237:686–691

    PubMed Central  PubMed  Google Scholar 

  13. Imamura H, Seyama Y, Kokudo N et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206

    Article  PubMed  Google Scholar 

  14. Jalan R, Olde Damink SW, Hayes PC et al (2004) Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol 41:613–620

    Article  CAS  PubMed  Google Scholar 

  15. McDonald DM, Thurston G, Baluk P (1999) Endothelial gaps as sites for plasma leakage in inflammation. Microcirculation 6:7–22

    Article  CAS  PubMed  Google Scholar 

  16. Nicoll A (2012) Surgical risk in patients with cirrhosis. J Gastroenterol Hepatol 27:1569–1575

    Article  PubMed  Google Scholar 

  17. Panis Y, McMullan DM, Emond JC (1997) Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery 121:142–149

    Article  CAS  PubMed  Google Scholar 

  18. Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724

    Article  PubMed  Google Scholar 

  19. Schroeder RA, Marroquin CE, Bute BP et al (2006) Predictive indices of morbidity and mortality after liver resection. Ann Surg 243:373–379

    Article  PubMed Central  PubMed  Google Scholar 

  20. Shaheen AA, Kaplan GG, Hubbard JN, Myers RP (2009) Morbidity and mortality following coronary artery bypass graft surgery in patients with cirrhosis: a population-based study. Liver Int 29:1141–1151

    Article  PubMed  Google Scholar 

  21. Tanaka K, Kumamoto T, Matsuyama R et al (2010) Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases. J Gastrointest Surg 14:359–368

    Article  PubMed  Google Scholar 

  22. Telem DA, Schiano T, Divino CM (2010) Complicated hernia presentation in patients with advanced cirrhosis and refractory ascites: management and outcome. Surgery 148:538–543

    Article  PubMed  Google Scholar 

  23. Tsien CD, McCullough AJ, Dasarathy S (2012) Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol 27:430–441

    Article  CAS  PubMed  Google Scholar 

  24. Van de Kerkhove MP, de Jong KP, Rijken AM et al (2003) MARS treatment in posthepatectomy liver failure. Liver Int 3:44–51

    Google Scholar 

  25. Vallance P, Moncada S (1991) Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 30:776–778

    Article  Google Scholar 

  26. Warnick P, Mai I, Klein F et al (2011) Safety of pancreatic surgery in patients with simultaneous liver cirrhosis: a single center experience. Pancreatology 11:24–29

    Article  PubMed  Google Scholar 

  27. Wilms C, Mueller L, Lenk C et al (2008) Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg 247:825–834

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. C. Wilms, A. Radtke, S. Beckebaum, V. Cicinatti und H.J. Schmidt geben an, dass kein Interessenkonflikt besteht. Der Beitrag enthält keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Wilms.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wilms, C., Radtke, A., Beckebaum, S. et al. Prävention und Therapie des postoperativen Leberversagens. Z Herz- Thorax- Gefäßchir 28, 216–221 (2014). https://doi.org/10.1007/s00398-014-1080-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00398-014-1080-0

Schlüsselwörter

Keywords

Navigation